English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/73440
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

The cyclopentenone 15-deoxy-D-12,14-Prostaglandin J2 inhibits G1/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer´s disease patients

AuthorsMuñoz, Úrsula ; De las Cuevas, Natividad; Bartolomé Robledo, Fernando ; García-Hermida, Ofelia; Bermejo-Pareja, Félix; Martín-Requero, Ángeles
KeywordsAlzheimer's disease
Lymphocytes
Cell cycle
Cyclopentenone
p27
Issue DateOct-2005
PublisherElsevier
CitationExperimental Neurology, 195 (2) : 508-517 (2005)
AbstractEpidemiologic studies indicated that non-steroidal anti-inflammatory drugs (NSAIDs) might prevent or delay the clinical features of Alzheimer disease (AD). The pharmacological activity of NSAIDs is generally attributed to inhibition of cyclooxygenase and peroxisome proliferator-activated receptor γ (PPARγ) activation. Based on the antineoplastic and apoptotic effects of PPARγ activation in a number of cell types, we hypothesized that NSAIDs could protect neurons by controlling the regulation of cell cycle. Recent work suggests that uncoordinated expression of cell cycle molecules and perturbation of cell cycle checkpoints may be one of the mechanisms by which post-mitotic neurons die. Since cell cycle dysfunction is not restricted to neurons in AD, we found it interesting to study the role of PPARγ activation on cell proliferation in immortalized lymphocytes from AD patients. We report here that 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2), but not NSAIDs or thiazolidinediones inhibited the serum-mediated enhancement of cell proliferation in AD by blocking the events critical for G1/S transition. The cyclopentenone induced a partial inhibition of retinoblastoma protein phosphorylation and increased levels of the CDK inhibitor p27kip1
Description10 páginas, 9 figuras -- PAGS nros. 508-517
Publisher version (URL)http://dx.doi.org/10.1016/j.expneurol.2005.06.010
URIhttp://hdl.handle.net/10261/73440
DOI10.1016/j.expneurol.2005.06.010
ISSN0014-4886
E-ISSN1090-2430
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
restringido.pdf21,67 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.